<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01617902</url>
  </required_header>
  <id_info>
    <org_study_id>HBCS_01</org_study_id>
    <nct_id>NCT01617902</nct_id>
  </id_info>
  <brief_title>Hyperbilirubinemia After Cardiac Surgery</brief_title>
  <official_title>Hyperbilirubinemia After Major Cardiac or Thoracic Aorta Surgery: Predictors and Clinical Significance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the incidence and risk factors of hyperbilirubinemia following
      major cardiac or thoracic aorta surgery, and to determine the clinical impacts of the
      hyperbilirubinemia on postoperative mortality and morbidity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients receiving elective cardiac or thoracic aorta surgery will be monitored for the
      development of postoperative hyperbilirubinemia. Collection of data will include patient
      baseline demographic characteristics, laboratory and echocardiographic findings, procedural
      factors of the surgery, and early postoperative variables. Serial postoperative liver
      function testings will be done during the hospitalization. Postoperative hyperbilirubinemia
      is defined as serum bilirubin level of 3mg/dL.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause-death</measure>
    <time_frame>Within 30 days after surgery or during postoperative hospitalization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>gastrointestinal or hepatobiliary complications requiring intervention</measure>
    <time_frame>Within 30 days after surgery or during postoperative hospitalization</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing elective major cardiac or thoracic aorta surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients aged over 18 years who are scheduled to undergo elective major cardiac or thoracic
        aorta surgery. Major cardiac surgery includes coronary artery bypass grafting,
        pericardiectomy and corrections of cardiac diseases using cardiopulmonary bypassing (valve
        surgery, tumor excision, arrhythmia surgery, heart transplantation, ventricular
        reconstruction, pulmonary thromboembolectomy, and atrial or ventricular septal defects
        closure).

        Exclusion Criteria:

          1. univentricular or one-and-half ventricle repairs

          2. presence of known liver cirrhosis or hepatic cancer

          3. history of liver transplantation

          4. Genetic diseases that affects bilirubin metabolism (i.e. Gilbert syndrome)

          5. preoperative bilirubin level of 3mg/dL or more.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon Bum Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joon Bum Kim, MD</last_name>
    <phone>82-2-3010-5416</phone>
    <email>jbkim1975@amc.seoul.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joon Bum Kim, MD</last_name>
      <phone>82-2-3010-5416</phone>
      <email>jbkim1975@amc.seoul.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2012</study_first_submitted>
  <study_first_submitted_qc>June 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2012</study_first_posted>
  <last_update_submitted>June 14, 2012</last_update_submitted>
  <last_update_submitted_qc>June 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Joon Bum Kim</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Hyperbilirubinemia</keyword>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <keyword>aorta</keyword>
  <keyword>prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

